Skip to Main Content

Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today boasts the aroma of blueberries — and get started. Meanwhile, do keep us in mind if you hear anything interesting. Hope you have a productive and meaningful day …

The fraud trial of a former Valeant Pharmaceuticals (VRX) executive is set to begin this week in Manhattan federal court, the first criminal prosecution to emerge from multiple investigations into the embattled drug maker over its sales practices, The Wall Street Journal writes. Using a statute often applied to public corruption cases, prosecutors accused Gary Tanner and a co-defendant, Andrew Davenport, of defrauding Valeant through an alleged multimillion-dollar kickback scheme involving Philidor Rx Services, a specialty mail-order pharmacy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • May I observe that while it does not seem inappropriate for Valeant to be involved in a fraud trial – but to have it apparently be “the victim” rather than the perpetrator gives one …. pause.

Comments are closed.